{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:00:50Z","timestamp":1790402450004,"version":"4.1.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"DOI":"10.1038\/s41531-026-01562-x","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:06:24Z","timestamp":1790337984000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Data from the ROPAD study corroborate an association between ITSN1 loss-of-function variants and Parkinson\u2019s disease"],"prefix":"10.1038","volume":"12","author":[{"given":"Christian A.","family":"Ganoza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Westenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jefri J.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipa","family":"Curado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma N.","family":"Somerville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Rennecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Beetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"key":"1562_CR1","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/s41531-024-00752-9","volume":"10","author":"AT Skuladottir","year":"2024","unstructured":"Skuladottir, A. T. et al. Loss-of-function variants in ITSN1 confer high risk of Parkinson\u2019s disease. npj Park. Dis. 10, 140 (2024).","journal-title":"npj Park. Dis."},{"key":"1562_CR2","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41531-025-01141-6","volume":"11","author":"G Cogan","year":"2025","unstructured":"Cogan, G. et al. Should ITSN1 be considered as a Mendelian Parkinson\u2019s disease gene? Description of three novel families. npj Park. Dis. 11, 295 (2025).","journal-title":"npj Park. Dis."},{"key":"1562_CR3","doi-asserted-by":"publisher","first-page":"115355","DOI":"10.1016\/j.celrep.2025.115355","volume":"44","author":"TP Spargo","year":"2025","unstructured":"Spargo, T. P. et al. Haploinsufficiency of ITSN1 is associated with a substantial increased risk of Parkinson\u2019s disease. Cell Rep. 44, 115355 (2025).","journal-title":"Cell Rep."},{"key":"1562_CR4","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1002\/mds.28416","volume":"36","author":"V Skrahina","year":"2021","unstructured":"Skrahina, V. et al. The Rostock International Parkinson\u2019s Disease (ROPAD) study: protocol and initial findings. Mov. Disord. 36, 1005\u20131010 (2021).","journal-title":"Mov. Disord."},{"key":"1562_CR5","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1093\/brain\/awae188","volume":"147","author":"A Westenberger","year":"2024","unstructured":"Westenberger, A. et al. Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson\u2019s disease study. Brain 147, 2652\u20132667 (2024).","journal-title":"Brain"},{"key":"1562_CR6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41436-018-0016-6","volume":"21","author":"P Bauer","year":"2019","unstructured":"Bauer, P. et al. Development of an evidence-based algorithm that optimizes sensitivity and specificity in ES-based diagnostics of a clinically heterogeneous patient population. Genet. Med. 21, 53\u201361 (2019).","journal-title":"Genet. Med."},{"key":"1562_CR7","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41431-020-00713-9","volume":"29","author":"AM Bertoli-Avella","year":"2021","unstructured":"Bertoli-Avella, A. M. et al. Successful application of genome sequencing in a diagnostic setting: 1007 index cases from a clinically heterogeneous cohort. Eur. J. Hum. Genet. 29, 141\u2013153 (2021).","journal-title":"Eur. J. Hum. Genet."},{"key":"1562_CR8","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz, C. G. et al. Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov. Disord. 23, 2129\u20132170 (2008).","journal-title":"Mov. Disord."},{"key":"1562_CR9","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma, R. B. et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov. Disord. 30, 1591\u20131601 (2015).","journal-title":"Mov. Disord."},{"key":"1562_CR10","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41586-023-06045-0","volume":"625","author":"S Chen","year":"2024","unstructured":"Chen, S. et al. A genomic mutational constraint map using variation in 76,156 human genomes. Nature 625, 92\u2013100 (2024).","journal-title":"Nature"},{"key":"1562_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(21)00218-x","author":"BR Bloem","year":"2021","unstructured":"Bloem, B. R., Okun, M. S. & Klein, C. Parkinson\u2019s disease. Lancet https:\/\/doi.org\/10.1016\/s0140-6736(21)00218-x (2021).","journal-title":"Lancet"},{"key":"1562_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41531-023-00608-8","volume":"10","author":"V Pitz","year":"2024","unstructured":"Pitz, V. et al. Analysis of rare Parkinson\u2019s disease variants in millions of people. npj Park. Dis. 10, 11 (2024).","journal-title":"npj Park. Dis."},{"key":"1562_CR13","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/s41588-022-01148-2","volume":"54","author":"X Zhou","year":"2022","unstructured":"Zhou, X. et al. Integrating de novo and inherited variants in 42,607 autism cases identifies mutations in new moderate-risk genes. Nat. Genet. 54, 1305\u20131319 (2022).","journal-title":"Nat. Genet."},{"key":"1562_CR14","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41431-021-00985-9","volume":"30","author":"AL Bruel","year":"2022","unstructured":"Bruel, A. L. et al. ITSN1: a novel candidate gene involved in autosomal dominant neurodevelopmental disorder spectrum. Eur. J. Hum. Genet. 30, 111\u2013116 (2022).","journal-title":"Eur. J. Hum. Genet."},{"key":"1562_CR15","doi-asserted-by":"publisher","first-page":"e215845","DOI":"10.1001\/jamanetworkopen.2021.5845","volume":"4","author":"RA Ortega","year":"2021","unstructured":"Ortega, R. A. et al. Association of dual LRRK2 G2019S and GBA variations with Parkinson disease progression. JAMA Netw. Open 4, e215845 (2021).","journal-title":"JAMA Netw. Open"}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01562-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01562-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01562-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:36:27Z","timestamp":1790400987000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01562-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1562"],"URL":"https:\/\/doi.org\/10.1038\/s41531-026-01562-x","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"assertion":[{"value":"18 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.A.G., J.J.P., F.C., E.N.S., J.R., P.B., and C.B. are current or former employees of CENTOGENE GmbH. A.W. is an advisor for medical writing and data analysis to CENTOGENE GmbH. The authors declare no competing financial or non-financial interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"237"}}